Method of blocking human 5-hydroxytryptamine-2 receptors
US5674875A · kind A · utility
1Cited by
4References
2Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 16, 1995 |
| Grant date | Oct 7, 1997 |
| Priority date | — |
| Expiry date | Feb 16, 2015 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/48
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
N-unsubstituted ergolines specifically bind to human 5-HT.sub.2 receptors, and are thus useful in treating diseases such as depression, hypertension and migraine.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.